Elysium Health™ Announces the Launch of SIGNAL™ for Metabolic Aging
NEW YORK, Jan. 25, 2022 /PRNewswire/ — Elysium Health, Inc.™, a leading life sciences company developing clinically validated health products based on advancements in aging research, today announced the launch of SIGNAL™, a novel combination of the most direct NAD+ precursor, NMN, and…
Comments Off on Elysium Health™ Announces the Launch of SIGNAL™ for Metabolic Aging